TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Reports $2.89 Million in Q3 Revenue Following Technology Business Transition

Company: MindWave Innovations Inc. (APUS)
Category: News

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) reported financial results for the third quarter ended Sept. 30, 2026, including revenue of $2.89 million, compared with no revenue a year earlier, marking its first full quarter of revenue from its technology business. The company generated $2.48 million from software development and deployment services for two enterprise customers, including one related party. Operating income totaled $2 million, while net income reached $33.6 million, or $19.13 per basic share, including a $25.26 million unrealized gain on digital assets. Total assets stood at $153.5 million, with shareholders’ equity of $140.5 million. Apimeds completed its transition from the biopharmaceutical sector following the July 14 disposal of its former biopharmaceutical subsidiary.

Through its wholly owned subsidiary MindWave Innovations, Apimeds signed technology services agreements with AQUAE Holdings and Flash Sports & Media Holdings in September, followed by a two-year master agreement with BlockAssure in October. MindWave also entered into a joint venture with Skalup Capital to establish an insurance and technology business in Bermuda, subject to regulatory licensing. Additional developments included the appointment of Eric Sherb as chief financial officer and $750,000 in subsidiary financing received in October.

To view the full press release, visit https://ibn.fm/4AoWe

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) operates through its wholly owned subsidiary, MindWave, which develops enterprise technology infrastructure and builds and operates dedicated networks for clients in climate finance, sports media, insurance and financial services.

About MindWave Innovations Inc.

MindWave develops enterprise blockchain infrastructure, including the MindChain network, and institutional platforms for regulated financial services, real-world asset digitization and enterprise applications. For more information, visit https://www.mindwaveinnovations.com/

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
Editor@TechMediaWire.com

TechMediaWire is powered by IBN

Contact us: (512) 354-7000